Pfizer Kicks Off Big Pharma Earnings With a Beat. The Stock Is Rising.

[admin]

Pfizer shares rose Tuesday after the pharmaceutical company beat earnings expectations and reaffirmed its full-year guidance. Pfizer reported adjusted earnings of 10 cents a share and revenue of $14.2 billion for the fourth quarter of 2023. Pfizer repeated its expectation of adjusted earnings of between $2.05 and $2.25 this year, and revenue between $58.5 billion and $61.5 billion.